Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Monte Rosa Therapeutics Inc
GLUECurrent price
5.69 USD
-0.31 USD (-5.17%)
Last closed
6.01 USD
Company
www.monterosatx.com
ISIN
US61225M1027
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
378 670 176 USD
Yield for 12 month
-5.17 %
1Y
3Y
5Y
10Y
15Y
GLUE
Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops MRT-2359, an orally bioavailable molecular glue degrader targeting the translation termination factor protein GSPT1 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of systemic and central nervous system autoimmune diseases; and MRT-8102 for the treatment of IL-1"/NLRP3 driven inflammatory diseases. It also develops CDK2 to treat ovarian, uterine, and breast cancers. The company was incorporated in 2019 and is headquartered in Boston, Massachusetts. Address: 321 Harrison Avenue, Boston, MA, United States, 02118
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
15.83 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+4 695 000 USD
Last Quarter
+1 064 000 USD
Current Year
-6 222 000 USD
Last Year
-8 559 000 USD
Current Quarter
+2 635 000 USD
Last Quarter
-833 000 USD
Key Figures GLUE
1 year
3 years
5 years
10 years
EBITDA
-131 783 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-27.99 %
PEG Ratio
–
Return On Equity TTM
-59.51 %
Wall Street Target Price
15.83 USD
Revenue TTM
5 759 000 USD
Book Value
3.66 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.22 USD
Diluted Eps TTM
-2.22 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics GLUE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GLUE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation GLUE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
27.9252
Price Sales TTM
65.7528
Enterprise Value EBITDA
-0.781
Price Book MRQ
1.6854
Financials GLUE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GLUE
For 52 weeks
2.44 USD
8.84 USD
50 Day MA
4.56 USD
Shares Short Prior Month
2 779 929
200 Day MA
5.11 USD
Short Ratio
14.06
Shares Short
2 790 585
Short Percent
8.31 %
BeatStart